...in the news

Systematic compilation of News-Relevant items on SBIR-STTR involved firms past and present.

Displaying 81 - 90 of 279 (10 per page)

OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
Omeros Announces Completion of Acquisition of Assay for GPCR Program
Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh: Drug Candidate Expands Company's Pipeline of Oncology Compounds Directed to Targets on Cancer Stem Cells and Tumor Bulk
Medivation to Expand Global Oncology Franchise with the Acquisition of All Worldwide Rights to Talazoparib (BMN 673), a Potent PARP Inhibitor, from BioMarin
Eiger BioPharmaceuticals Announces Acquisition of Exclusive License to Program for Treatment of Post-Bariatric Hypoglycemia from Stanford University: Clinical Proof of Concept Data Already Generated in Patients
MRIGlobal, Evogen Announce Agreement in Development of Diagnostic Solutions
Valencell Files Patent Infringement Suit against Apple, Inc. and Fitbit, Inc.
Case Western Reserve University grants exclusive license to Folio Photonics: Research spin-off developing archival optical data storage
Quick-Med Signs License with Medline to Provide Stay-Fresh(R) Antimicrobial Technology for Traditional Wound Care Products
BioKier Inc. signs exclusive global license with UCL Business PLC for colonic delivery of gut hormone secretagogues for treatment of metabolic diseases including diabetes